Alpha-1-antitrypsin phenotypes and HLA-B27 typing in uveitis patients in southeast Iran

Clinical Biochemistry

Volumn 38, Issue 5, 2005, Pages 425-432

  Ghavami, Saeid ^a,g   Hashemi, Mohammad ^a   Shahriari, Hossain Ali ^a   Bajestani, Saeed Naghibzadeh ^a,b   De Serres, Frederick J ^c   Moghaddam, Ebrahim Miri ^a   Kazemi, Morteza ^a   Alavian, Seyed Moayed ^d   Taheri, Mohsen ^a   Blanco, Ignacio ^e   Fernandez Bustillo, Enrique ^f  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF FLORIDA   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e HOSPITAL VALLE DEL NALÓN   (Spain)

^f HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Alpha 1 antitrypsin deficiency; HLA B27; Inflammatory eye diseases; Isoelectric focusing; Uveitis

Indexed keywords

ALPHA 1 ANTITRYPSIN; HLA B27 ANTIGEN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CONTROLLED STUDY; HLA TYPING; HUMAN; IMMUNOPHENOTYPING; IRAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; UVEITIS;

EID: 20144388208     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2005.02.006     Document Type: Article

References (47)

1. D. Wakefield, S.N. Breit, P. Clark, and R. Penny Immunogenetic factors in inflammatory eye disease. Influence of HLA-B27 and alpha 1-antitrypsin phenotypes on disease expression Arthritis Rheum. 25 1982 1431 1434
2. D. BenEzra, E. Cohen, and G. Maftzir Prediction of treatment outcome in uveitis Dev. Ophthalmol. 31 1999 160 165
3. M.W. Belin Update on occular allergy Focal Points 12 1994 1 11
4. N.A. Rao, W.B. Wacxker, and G.E. Mark Experimental allergic uveitis: clinicopathologic factors associated with varying doses of s antigen Arch. Ophtalmol. 97 1979 1954 1958
5. N.A. Rao Role of oxygen free radicals damage associated with experimental uveitis Trans. Am. Ophthalmol. 88 1990 797 850
6. N.A. Rao, and W. Guey-Shuang Free radical mediated photoreceptor damage in uveitis Prog. Retin. Eye Res. 19 2000 41 68
7. A.D. Dick Immune mechanisms of uveitis; insights into disease pathogenesis and treatment Int. Ophthalmol. Clin. 40 2000 1 18
8. D.A. Johnson, R.N. Pannell, and J. Travis The molecular stoichiometry of trypsin inhibition by human alpha-1-proteinase inhibitor Biochem. Biophys. Res. Commun. 57 1974 584 589
9. E.T. Littleton, L. Bevis, and L.J. Hansen Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease J. Clin. Pathol. 44 1991 855 858
10. P.K. Arora, H.C. Miller, and L.D. Aronson Alpha1-antitrypsin is an effector of immunological stasis Nature 274 1978 589 590
11. R.A. Stockley Proteases and antiproteases Chronic obstructive pulmonary disease: pathogenesis to treatment 2001 John Wiley and Sons Ltd. 189 204
12. M. Fagerhol, and D. Cox The pi polymorphism: genetic, biochemical, and clinical aspects of human alpha 1-antitrypsin Advances in genetics 1981 1 62
13. M.L. Brantly, L.D. Paul, and B.H. Miller Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms Am. Rev. Respir. Dis. 138 1988 327 336
14. WHO AAT deficiency 1996 World Health Organization Geneva
15. D.W. Cox Alpha-1 antitrypsin deficiency Metabolic basis of inherited diseases 1994 2532 2568
16. D.W. Cox Alpha 1-antitrypsin: a guardian of vascular tissue Mayo Clin. Proc. 69 1994 1123 1124
17. M. Brantly, T. Nukiwa, and R.G. Crystal Molecular basis of alpha-1-antitrypsin deficiency Am. J. Med. 84 1988 13 31
18. J.A. Pierce Antitrypsin and emphysema. Perspective and prospects JAMA 259 1988 2890 2895
19. B.C. Byth, G.D. Billingsley, and D.W. Cox Physical and genetic mapping of the serpin gene cluster at 14q32.1: allelic association and a unique haplotype associated with alpha 1-antitrypsin deficiency Am. J. Hum. Genet. 55 1994 126 133
20. C.A. Blank, and M. Brantly Clinical features and molecular characteristics of alpha 1-antitrypsin deficiency Ann. Allergy 72 1994 105 120 [quiz 120-102]
21. R.W. Carrell, and D.A. Lomas Mechanisms of disease-alpha(1)-antitrypsin deficiency-a model for conformational diseases N. Engl. J. Med. 346 2002 45 53
22. R.W. Carrell, J.O. Jeppsson, and C.B. Laurell Structure and variation of human alpha 1-antitrypsin Nature 298 1982 329 334
23. T. Nukiwa, M. Brantly, and R. Garver Evaluation of "at risk" alpha 1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes J. Clin. Invest. 77 1986 528 537
24. R. Mahadeva, and D.A. Lomas Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema Thorax 53 1998 501 505
25. J. Constans, M. Viau, and C. Gouaillard Pi M4: an additional Pi M subtype Hum. Genet. 55 1980 119 121
26. I.R. Fearnley, D.J. Spalton, A.M. Ward, B. Slavin, and F. Muncey Alpha 1-antitrypsin phenotypes in acute anterior uveitis Br. J. Ophthalmol. 72 1988 636 639
27. A.N. Elzouki, S. Lindgren, S. Nilsson, B. Veress, and S. Eriksson Severe alpha1-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation J. Hepatol. 26 1997 1403 1407
28. F.J. de Serres Worldwide racial and ethnic distribution of alpha(1)-antitrypsin deficiency-summary of an analysis of published genetic epidemiologic surveys Chest 122 2002 1818 1829
29. F.J. de Serres Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed Environ. Health Perspect. 111 2003 1851 1854
30. F.J. de Serres, I. Blanco, and E. Fernandez-Bustillo Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain Clin. Genet. 63 2003 490 509
31. F.J. de Serres, I. Blanco, and E. Fernandez-Bustillo Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand Australia, Canada, New Zealand and the United States of America Clin. Genet. 64 2003 382 397
32. C.B. Laurell, and S. Eriksson The electrophoretic alpha-1-globulin pattern of serum in alpha1-antiytypsin deficiency Scand. J. Clin. Lab. Invest. 15 1963 132 140
33. H.L. Sharp, R.A. Bridges, W. Krivit, and E.F. Freier Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder J. Lab. Clin. Med. 73 1969 934 939
34. D.A. Brewerton The genetics of acute anterior uveitis Trans. Ophthalmol. Soc. U. K. 104 1985 248 249
35. D.A. Brewerton, M. Webley, A.H. Murphy, and A.M. Ward The alpha 1-antitrypsin phenotype MZ in acute anterior uveitis Lancet 8073 1978 1103
36. G. Grabner, V. Pausch, and W.R. Mayr Alpha-1-antitrypsin phenotypes in acute anterior uveitis Ophthalmic Res. 14 1982 1 4
37. P. Moller, and M.K. Fagerhol Pi phenotypes in patients with ankylosing spondylitis, acute anterior uveitis, psoriasis and chronic prostatitis Clin. Genet. 26 1984 339 341
38. P. Terasaki, and J. McClelland Microdroplet assay of human serum cytotoxins Nature 204 1964 998 1000
39. J.O. Jeppsson, and B. Franzen Typing of genetic variants of alpha 1-antitrypsin by electrofocusing Clin. Chem. 28 1982 219 225
40. L. Gaidulis, H.A. Muensch, W.C. Maslow, and W.Z. Borer Optimizing reference values for the measurement of alpha 1-antitrypsin in serum: comparison of three methods Clin. Chem. 29 1983 1838 1840
41. A.A. Dietz, H.M. Rubinstein, and L.K. Hodges Measurment of alpha 1 antitrypsin in serum, by immunodiffusion and enzymatic assay Clin. Chem. 20 1974 396 399
42. W.T. Brown, A.E. Mamelok, and A.G. Bearn Anterior uveitis and alpha-1-antitrypsin Lancet 8143 1979 646
43. E.L. Howes, and N.A. Rao Basic mechanisms in pathology 1996 2935 3044
44. S.N. Breit, and R. Penny The role of alpha 1 protease inhibitor (alpha 1 antitrypsin) in the regulation of immunologic and inflammatory reactions Aust. N. Z. J. Med. 10 1980 449 453
45. S.N. Breit, J.P. Robinson, and R. Penny The effect of alpha 1 antitrypsin on phagocyte function J. Clin. Lab. Immunol. 10 1983 147 149
46. M. Whiteman, and B. Halliwell Protection against peroxynitrite-dependent tyrosine nitration and alpha 1-antiproteinase inactivation by ascorbic acid. A comparison with other biological antioxidants Free Radical Res. 25 1996 275 283
47. D.W. Cox Ethnic differences in reactions to drugs and xenobiotics. Clinical and molecular studies of alpha 1-antitrypsin deficiency Prog. Clin. Biol. Res. 214 1986 373 384